Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
26.27
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
7 High-Value Stocks With Massive Wealth-Building Potential
March 22, 2024
Explore high-value stocks shaping the future across semiconductors, digital payments, AI, and healthcare for savvy investors.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge
March 22, 2024
Legal actions surge against diabetes drug manufacturers Eli Lilly and Novo Nordisk. Patients allege severe complications, including gallbladder issues and gastroparesis, tied to GLP-1 agonists. Over 60...
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease
March 21, 2024
Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neuropathy. The therapy demonstrated safety and efficacy in children with GAN,...
Via
Benzinga
Pfizer Options Trading: A Deep Dive into Market Sentiment
March 21, 2024
Via
Benzinga
Is Pfizer the Best Dividend Stock for You?
March 21, 2024
Pfizer's stock is cheap, and it pays an incredibly high yield right now.
Via
The Motley Fool
Decoding Pfizer's Options Activity: What's the Big Picture?
March 15, 2024
Via
Benzinga
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
March 21, 2024
Ark, through its flagship Ark Innovation ETF and Ark Genomic Revolution ETF, has been brisk with its acquisition of Moderna shares in March.
Via
Benzinga
Topics
ETFs
Exposures
COVID-19
EXCLUSIVE: Health Care Experts Discuss Critical Need For An Equitable System
March 20, 2024
Former Pfizer CMO Dr. Freda Lewis-Hall and ICR Westwicke's Michael O'Brien discuss challenges in autoimmune disease treatment and healthcare innovation.
Via
Benzinga
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
March 20, 2024
BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandemic with their jointly developed vaccine.
Via
Benzinga
Exposures
COVID-19
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
March 20, 2024
BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance.
Via
Investor's Business Daily
Why Is BioNTech Stock Trading Lower On Wednesday?
March 20, 2024
BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5-€3.1 billion,...
Via
Benzinga
3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50
March 19, 2024
These dividend stocks selling for under $50 with yields of 5% or more offer a lot to investors at any time making these strong buys.
Via
InvestorPlace
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
March 18, 2024
Pfizer to reduce stake in Haleon to approximately 24% following earlier divestment announcement. Offer price per share to be revealed post book-building process by Haleon.
Via
Benzinga
7 Dangerous Dividend Stocks to Avoid at All Costs: March 2024
March 18, 2024
Lurking in the weeds like a tiger ready to strike, these dangerous dividend stocks are set to wreak havoc on any investment portfolio.
Via
InvestorPlace
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move
March 18, 2024
Pfizer just might be one of the biggest comeback stories of the second half of this decade.
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
March 16, 2024
These stocks could be cheap only for a season.
Via
The Motley Fool
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
March 15, 2024
Immuneering shares dip as analysts express concern over IMM-1-104 trial results. Needham downgrades, citing efficacy issues despite promising mechanism of action. Optimism remains for earlier-stage...
Via
Benzinga
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
March 15, 2024
Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.
Via
InvestorPlace
Is Pfizer Stock a Millionaire Maker?
March 15, 2024
A couple of years ago, Pfizer's shares may have seemed like a sure thing. That may not be the case anymore.
Via
The Motley Fool
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
March 15, 2024
If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.
Via
InvestorPlace
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Via
The Motley Fool
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
Amidst regulatory challenges, WuXi AppTec faces backlash from industry giants. Biotechnology Innovation Organization cuts ties, citing national security concerns. Shares plummet as U.S. bills target...
Via
Benzinga
How To Earn $500 A Month From Pfizer Stock After A Surprise Profit-Turning Quarter
March 14, 2024
Pfizer Inc. (NYSE: PFE) shares closed slightly higher on Wednesday.
Via
Benzinga
The 3 Most Undervalued Healthcare Stocks to Buy in March 2024
March 14, 2024
Wager on these promising undervalued healthcare stocks, catering to investors aiming to leverage growth within the dynamic healthcare space.
Via
InvestorPlace
Want $2K Per Month in Retirement? Buy These 3 Dividend Stocks Now.
March 14, 2024
Investors wanting to enjoy some passive income during retirement should invest in these 3 dividend stocks.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
3 Stocks I'm Adding to My Retirement Account in March
March 14, 2024
A handful of names offer a combination of reliability and opportunity that many other stocks don't right now.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
Be A Smart Investor – Don’t Hold On For Dear Life
March 13, 2024
You have to give credit where it’s due. The bulls have been relentless for almost 18 months, but certainly over the past 5 months.
Via
Talk Markets
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
March 13, 2024
These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.